Stereotactic radiation therapy with concurrent immunotherapy for recurrent glioblastoma-hope or hype?
作者信息
Tsien Christina
机构信息
Department of Radiation Oncology, Johns Hopkins Medicine, Baltimore, MD, USA.
出版信息
Neuro Oncol. 2021 Apr 12;23(4):535-536. doi: 10.1093/neuonc/noab029.
Abstract
摘要
相似文献
1
Stereotactic radiation therapy with concurrent immunotherapy for recurrent glioblastoma-hope or hype?立体定向放射治疗联合免疫疗法治疗复发性胶质母细胞瘤——希望还是炒作？
Neuro Oncol. 2021 Apr 12;23(4):535-536. doi: 10.1093/neuonc/noab029.
2
Stereotactic radiosurgery and bevacizumab for recurrent glioblastoma multiforme.立体定向放射外科和贝伐单抗治疗复发性多形性胶质母细胞瘤。
J Natl Compr Canc Netw. 2012 Jun 1;10(6):695-9. doi: 10.6004/jnccn.2012.0072.
3
Efficacy and limitations of stereotactic radiosurgery in the treatment of glioblastoma.立体定向放射外科治疗胶质母细胞瘤的疗效与局限性
Neurol Med Chir (Tokyo). 2012;52(8):548-52. doi: 10.2176/nmc.52.548.
4
Multicenter, Phase 1, Dose Escalation Study of Hypofractionated Stereotactic Radiation Therapy With Bevacizumab for Recurrent Glioblastoma and Anaplastic Astrocytoma.贝伐单抗联合超分割立体定向放射治疗复发性胶质母细胞瘤和间变性星形细胞瘤的多中心、1期剂量递增研究
Int J Radiat Oncol Biol Phys. 2017 Nov 15;99(4):797-804. doi: 10.1016/j.ijrobp.2017.06.2466. Epub 2017 Jun 30.
5
Patterns of relapse in patients with high grade glioma receiving combined treatments including stereotactic re-irradiation for a first relapse.接受包括立体定向再照射治疗首次复发在内的联合治疗的高级别胶质瘤患者的复发模式。
Cancer Radiother. 2016 Jun;20(4):282-91. doi: 10.1016/j.canrad.2016.03.006. Epub 2016 Jun 16.
6
Hypofractionated stereotactic re-irradiation with pembrolizumab and bevacizumab in patients with recurrent high-grade gliomas: results from a phase I study.帕博利珠单抗和贝伐单抗用于复发性高级别胶质瘤患者的低分割立体定向再照射：一项I期研究的结果
Neuro Oncol. 2021 Apr 12;23(4):677-686. doi: 10.1093/neuonc/noaa260.
7
Role of adjuvant or salvage radiosurgery in the management of unresected residual or progressive glioblastoma multiforme in the pre-bevacizumab era.在贝伐单抗时代之前，辅助性或挽救性放射外科手术在多形性胶质母细胞瘤未切除的残留或进展病例管理中的作用。
J Neurosurg. 2015 Apr;122(4):757-65. doi: 10.3171/2014.11.JNS13295. Epub 2015 Jan 16.
8
Re-Irradiation with Stereotactic Radiosurgery/Radiotherapy for Recurrent High-Grade Gliomas: Improved Survival in the Modern Era.立体定向放射外科手术/放射治疗复发性高级别胶质瘤的再照射：现代时代生存率的提高
Stereotact Funct Neurosurg. 2018;96(5):289-295. doi: 10.1159/000493545. Epub 2018 Nov 7.
9
Salvage gamma knife stereotactic radiosurgery followed by bevacizumab for recurrent glioblastoma multiforme: a case-control study.挽救性伽玛刀立体定向放射外科联合贝伐珠单抗治疗复发性多形性胶质母细胞瘤：一项病例对照研究。
J Neurooncol. 2012 Apr;107(2):323-33. doi: 10.1007/s11060-011-0744-9. Epub 2011 Nov 5.
10
Stereotactic radiosurgery for intracranial gliomas.立体定向放射外科治疗颅内胶质瘤。
Neurosurg Clin N Am. 2013 Oct;24(4):605-12. doi: 10.1016/j.nec.2013.05.010. Epub 2013 Aug 2.
引用本文的文献
1
Synergies between radiotherapy and immunotherapy: a systematic review from mechanism to clinical application.放疗与免疫治疗之间的协同作用：从机制到临床应用的系统综述
Front Immunol. 2025 Aug 11;16:1554499. doi: 10.3389/fimmu.2025.1554499. eCollection 2025.
2
[Establishment of an Engineered Bacterial Membrane Biomimetic Nanodrug Delivery System and Its Role in the Treatment of Glioma].[工程化细菌膜仿生纳米药物递送系统的构建及其在胶质瘤治疗中的作用]
Sichuan Da Xue Xue Bao Yi Xue Ban. 2024 Jul 20;55(4):861-871. doi: 10.12182/20240760203.
3
Ropivacaine represses the proliferation, invasion, and migration of glioblastoma via modulating the microRNA-21-5p/KAT8 regulatory NSL complex subunit 2 axis.罗哌卡因通过调节 microRNA-21-5p/KAT8 调节性 NSL 复合物亚基 2 轴抑制胶质母细胞瘤的增殖、侵袭和迁移。
Bioengineered. 2022 Mar;13(3):5975-5986. doi: 10.1080/21655979.2022.2037955.
本文引用的文献
1
Randomized Phase II and Biomarker Study of Pembrolizumab plus Bevacizumab versus Pembrolizumab Alone for Patients with Recurrent Glioblastoma.帕博利珠单抗联合贝伐珠单抗对比帕博利珠单抗单药治疗复发性胶质母细胞瘤的随机 II 期及生物标志物研究。
Clin Cancer Res. 2021 Feb 15;27(4):1048-1057. doi: 10.1158/1078-0432.CCR-20-2500. Epub 2020 Nov 16.
2
Hypofractionated stereotactic re-irradiation with pembrolizumab and bevacizumab in patients with recurrent high-grade gliomas: results from a phase I study.帕博利珠单抗和贝伐单抗用于复发性高级别胶质瘤患者的低分割立体定向再照射：一项I期研究的结果
Neuro Oncol. 2021 Apr 12;23(4):677-686. doi: 10.1093/neuonc/noaa260.
3
Effect of Nivolumab vs Bevacizumab in Patients With Recurrent Glioblastoma: The CheckMate 143 Phase 3 Randomized Clinical Trial.纳武利尤单抗对比贝伐珠单抗治疗复发性胶质母细胞瘤患者的效果：CheckMate 143 期随机临床试验。
JAMA Oncol. 2020 Jul 1;6(7):1003-1010. doi: 10.1001/jamaoncol.2020.1024.
4
Author Correction: Immune and genomic correlates of response to anti-PD-1 immunotherapy in glioblastoma.作者更正：胶质母细胞瘤中抗PD-1免疫疗法反应的免疫和基因组相关性
Nat Med. 2019 Jun;25(6):1022. doi: 10.1038/s41591-019-0449-8.
5
Late Effects of Radiation Prime the Brain Microenvironment for Accelerated Tumor Growth.辐射的晚期效应使脑微环境为肿瘤加速生长做好准备。
Int J Radiat Oncol Biol Phys. 2019 Jan 1;103(1):190-194. doi: 10.1016/j.ijrobp.2018.08.033. Epub 2018 Aug 30.
6
Combination Therapy with Anti-PD-1, Anti-TIM-3, and Focal Radiation Results in Regression of Murine Gliomas.抗PD-1、抗TIM-3与局部放疗联合治疗可使小鼠胶质瘤消退。
Clin Cancer Res. 2017 Jan 1;23(1):124-136. doi: 10.1158/1078-0432.CCR-15-1535. Epub 2016 Jun 29.
7
Anti-PD-1 blockade and stereotactic radiation produce long-term survival in mice with intracranial gliomas.抗 PD-1 阻断和立体定向放疗可使颅内神经胶质瘤小鼠长期存活。
Int J Radiat Oncol Biol Phys. 2013 Jun 1;86(2):343-9. doi: 10.1016/j.ijrobp.2012.12.025. Epub 2013 Feb 22.
Zotero 插件